ketoconazole has been researched along with Kidney Diseases in 16 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ketoconazole treatment at a dose of 10 mg/kg daily for 60 days was not as effective as amphotericin B." | 5.27 | Treatment of canine blastomycosis with amphotericin B and ketoconazole. ( Edwards, DF; Legendre, AM; Selcer, BA; Stevens, R, 1984) |
| "Miconazole is a parenterally administered agent for patients acutely ill with candidiasis and other mycotic infections." | 2.36 | Antifungal agents used in systemic mycoses. Activity and therapeutic use. ( Craven, PC; Graybill, JR, 1983) |
| "Cushing's syndrome is known to present with a characteristic set of clinical manifestations and complications, well described in literature." | 1.51 | Arterial thrombosis as primary presentation of endogenous Cushing's syndrome. ( Alexander, V; Carey, RA; Dasgupta, R; Koshy, M, 2019) |
| "Ketoconazole treatment at a dose of 10 mg/kg daily for 60 days was not as effective as amphotericin B." | 1.27 | Treatment of canine blastomycosis with amphotericin B and ketoconazole. ( Edwards, DF; Legendre, AM; Selcer, BA; Stevens, R, 1984) |
| " Gentamicin at toxic doses, however, increased CSA nephrotoxicity." | 1.27 | Experimental cyclosporine nephrotoxicity: risk of concomitant chemotherapy. ( Mihatsch, MJ; Müller, AM; Ryffel, B, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (56.25) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, Q | 1 |
| Yin, L | 1 |
| Hartmann, RW | 1 |
| Alexander, V | 1 |
| Koshy, M | 1 |
| Dasgupta, R | 1 |
| Carey, RA | 1 |
| Shi, J | 1 |
| Chapel, S | 1 |
| Montay, G | 1 |
| Hardy, P | 1 |
| Barrett, JS | 1 |
| Sica, D | 1 |
| Swan, SK | 1 |
| Noveck, R | 1 |
| Leroy, B | 1 |
| Bhargava, VO | 1 |
| Brass, C | 1 |
| Galgiani, JN | 2 |
| Blaschke, TF | 1 |
| Defelice, R | 1 |
| O'Reilly, RA | 1 |
| Stevens, DA | 2 |
| Graybill, JR | 1 |
| Craven, PC | 1 |
| Legendre, AM | 1 |
| Selcer, BA | 1 |
| Edwards, DF | 1 |
| Stevens, R | 1 |
| Piketty, C | 1 |
| George, F | 1 |
| Weiss, L | 1 |
| Lavarde, V | 1 |
| Hernigou, A | 1 |
| Kazatchkine, MD | 1 |
| García, R | 1 |
| Marín, C | 1 |
| Herrera, J | 1 |
| Henríquez La Roche, C | 1 |
| Rubio, L | 1 |
| Rodríguez-Iturbe, B | 1 |
| Kramer, MR | 1 |
| Marshall, SE | 1 |
| Denning, DW | 2 |
| Keogh, AM | 1 |
| Tucker, RM | 1 |
| Lewiston, NJ | 1 |
| Theodore, J | 1 |
| Nováková, I | 1 |
| Donnelly, P | 1 |
| de Witte, T | 1 |
| de Pauw, B | 1 |
| Boezeman, J | 1 |
| Veltman, G | 1 |
| Ackerbauer, H | 1 |
| Meingassner, JG | 1 |
| Mieth, H | 1 |
| Davies, SP | 1 |
| Webb, WJ | 1 |
| Patou, G | 1 |
| Murray, WK | 1 |
| Ryffel, B | 1 |
| Müller, AM | 1 |
| Mihatsch, MJ | 1 |
| Whiting, PH | 1 |
| Thomson, AW | 1 |
| Simpson, JG | 1 |
| Haddy, RI | 1 |
| Petry, LJ | 1 |
| Bond, JA | 1 |
| Shelton, JA | 1 |
| Day, CM | 1 |
| Curry, RW | 1 |
| Bidgood, WD | 1 |
2 reviews available for ketoconazole and Kidney Diseases
| Article | Year |
|---|---|
Antifungal agents used in systemic mycoses. Activity and therapeutic use.
Topics: Amphotericin B; Antifungal Agents; Central Nervous System; Flucytosine; Humans; Imidazoles; Ketocona | 1983 |
Cyclosporine: toxicity, metabolism, and drug interactions--implications from animal studies.
Topics: Animals; Cyclosporins; Disease Models, Animal; Dogs; Drug Interactions; Gentamicins; Humans; Ketocon | 1985 |
1 trial available for ketoconazole and Kidney Diseases
| Article | Year |
|---|---|
Effect of ketoconazole on the pharmacokinetics and safety of telithromycin and clarithromycin in older subjects with renal impairment.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Area Under Curve; Biological Availability; Clarithro | 2005 |
13 other studies available for ketoconazole and Kidney Diseases
| Article | Year |
|---|---|
Aldosterone synthase inhibitors as promising treatments for mineralocorticoid dependent cardiovascular and renal diseases.
Topics: Aldosterone; Animals; Benzimidazoles; Cardiovascular Diseases; Cytochrome P-450 CYP11B2; Fadrozole; | 2014 |
Arterial thrombosis as primary presentation of endogenous Cushing's syndrome.
Topics: Adrenocorticotropic Hormone; Adult; Anticoagulants; Aortic Diseases; Celiac Artery; Computed Tomogra | 2019 |
Disposition of ketoconazole, an oral antifungal, in humans.
Topics: Administration, Oral; Adult; Antacids; Antifungal Agents; Child; Drug Interactions; Humans; Imidazol | 1982 |
Treatment of canine blastomycosis with amphotericin B and ketoconazole.
Topics: Amphotericin B; Animals; Blastomycosis; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Ketoc | 1984 |
Renal aspergilloma in AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Aspe | 1993 |
Systemic antifungal drugs.
Topics: Amphotericin B; Anorexia; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidom | 1997 |
[Usefulness of ketoconazole combined with cyclosporin in renal transplantation].
Topics: Adolescent; Adult; Azathioprine; Biotransformation; Chemical and Drug Induced Liver Injury; Cyclospo | 1991 |
Cyclosporine and itraconazole interaction in heart and lung transplant recipients.
Topics: Aspergillosis; Coccidiosis; Cyclosporins; Drug Interactions; Heart Transplantation; Heart-Lung Trans | 1990 |
Itraconazole and cyclosporin nephrotoxicity.
Topics: Antifungal Agents; Cyclosporins; Drug Interactions; Drug Therapy, Combination; Humans; Itraconazole; | 1987 |
[Experimental renal infection with Aspergillus fumigatus in mice: a chemotherapeutic model of an organic mycosis].
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, An | 1985 |
Renal aspergilloma--a case illustrating the problems of medical therapy.
Topics: Amphotericin B; Aspergillosis; Female; Flucytosine; Humans; Ketoconazole; Kidney Diseases; Middle Ag | 1987 |
Experimental cyclosporine nephrotoxicity: risk of concomitant chemotherapy.
Topics: Amphotericin B; Animals; Anti-Infective Agents; Cyclosporins; Drug Interactions; Gentamicins; Ketoco | 1986 |
Renal pelvocalyceal abscess secondary to Candida albicans.
Topics: Abscess; Candidiasis; Female; Humans; Ketoconazole; Kidney Diseases; Kidney Pelvis; Middle Aged | 1986 |